Ultimovacs ASA

Ultimovacs ASAverified

ULTI.OL

Price:

$2.05

Market Cap:

$70.53M

Ultimovacs ASA, a pharmaceutical company, develops immunotherapies for cancers. Its lead product candidate is UV1, a peptide-based vaccine that induces T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.

Industry

Biotechnology

IPO Date

2019-06-03

Stock Exchange

OSL

Ticker

ULTI.OL

The PE Ratio as of December 2025 (TTM) for Ultimovacs ASA (ULTI.OL) is -0.35

According to Ultimovacs ASA’s latest financial reports and current stock price. The company's current PE Ratio is -0.35. This represents a change of -74.81% compared to the average of -1.40 of the last 4 quarters.

Ultimovacs ASA (ULTI.OL) Historical PE Ratio (quarterly & annually)

How has ULTI.OL PE Ratio performed in the past?

The mean historical PE Ratio of Ultimovacs ASA over the last ten years is -14.74. The current -0.35 PE Ratio has changed 139.82% with respect to the historical average. Over the past ten years (40 quarters), ULTI.OL's PE Ratio was at its highest in in the December 2024 quarter at -0.19. The PE Ratio was at its lowest in in the June 2022 quarter at -64.18.

Quarterly (TTM)
Annual

Average

-14.74

Median

-16.36

Minimum

-25.64

Maximum

0

Ultimovacs ASA (ULTI.OL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Ultimovacs ASA PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 74.66%

Maximum Annual PE Ratio = 0

Minimum Annual Increase = -Infinity%

Minimum Annual PE Ratio = -25.64

Quarterly (TTM)
Annual
YearPE RatioChange
20240-100.00%
2023-22.32-12.96%
2022-25.6417.11%
2021-21.905.58%
2020-20.7428.89%
2019-16.0974.66%
2018-9.21-37.90%
2017-14.84-10.82%
2016-16.64-Infinity%

Ultimovacs ASA (ULTI.OL) Average PE Ratio

How has ULTI.OL PE Ratio performed in the past?

The current PE Ratio of Ultimovacs ASA (ULTI.OL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-15.99

5-year avg

-18.12

10-year avg

-14.74

Ultimovacs ASA (ULTI.OL) PE Ratio vs. Peers

How is ULTI.OL’s PE Ratio compared to its peers?

Ultimovacs ASA’s PE Ratio is greater than BerGenBio ASA (-0.43), less than Nordic Nanovector ASA (0), less than Targovax ASA (-0.26), greater than Nykode Therapeutics AS (-1.85), greater than PCI Biotech Holding ASA (-0.46),

Build a custom stock screener for Ultimovacs ASA (ULTI.OL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ultimovacs ASA using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ultimovacs ASA (ULTI.OL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ultimovacs ASA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Ultimovacs ASA's PE Ratio?

How is the PE Ratio calculated for Ultimovacs ASA (ULTI.OL)?

What is the highest PE Ratio for Ultimovacs ASA (ULTI.OL)?

What is the 3-year average PE Ratio for Ultimovacs ASA (ULTI.OL)?

What is the 5-year average PE Ratio for Ultimovacs ASA (ULTI.OL)?

How does the current PE Ratio for Ultimovacs ASA (ULTI.OL) compare to its historical average?